Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD

American Journal of Kidney Diseases

Volumn 62, Issue 1, 2013, Pages 58-66

  Damasiewicz, Matthew J ^a,b   Magliano, Dianna J ^c   Daly, Robin M ^d,e   Gagnon, Claudia ^e,f   Lu, Zhong X ^b,g   Sikaris, Ken A ^g   Ebeling, Peter R ^e   Chadban, Steven J ^h,i   Atkins, Robert C ^c   Kerr, Peter G ^a,b   Shaw, Jonathan E ^c   Polkinghorne, Kevan R ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d DEAKIN UNIVERSITY   (Australia)

^e UNIVERSITY OF MELBOURNE   (Australia)

^f Université Laval   (Canada)

^g MELBOURNE PATHOLOGY   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

Author keywords

albuminuria; chronic kidney disease; decreased kidney function; glomerular filtration rate; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; CREATININE;

ADULT; AGED; ALBUMINURIA; ARTICLE; CHRONIC KIDNEY DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; VITAMIN D DEFICIENCY;

ADULT; AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84879422068     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.03.010     Document Type: Article

References (53)

1. Y.C. Li Renoprotective effects of vitamin D analogs Kidney Int 78 2 2010 134 139
2. A. Verstuyf, G. Carmeliet, R. Bouillon, C. Mathieu Vitamin D: a pleiotropic hormone Kidney Int 78 2 2010 140 145
3. J. Coresh, E. Selvin, L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 17 2007 2038 2047
4. P. Ruggenenti, A. Perna, L. Mosconi, R. Pisoni, G. Remuzzi Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN) Kidney Int 53 5 1998 1209 1216
5. H.C. Gerstein, J.F. Mann, Q. Yi Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals JAMA 286 4 2001 421 426
6. D.J. Magliano, K.R. Polkinghorne, E.L. Barr HPLC-detected albuminuria predicts mortality J Am Soc Nephrol 18 12 2007 3171 3176
7. A.B. Shoben, K.D. Rudser, I.H. de Boer, B. Young, B. Kestenbaum Association of oral calcitriol with improved survival in nondialyzed CKD J Am Soc Nephrol 19 8 2008 1613 1619
8. M. Naves-Diaz, D. Alvarez-Hernandez, J. Passlick-Deetjen Oral active vitamin D is associated with improved survival in hemodialysis patients Kidney Int 74 8 2008 1070 1078
9. M. Teng, M. Wolf, M.N. Ofsthun Activated injectable vitamin D and hemodialysis survival: a historical cohort study J Am Soc Nephrol 16 4 2005 1115 1125
10. M. Wolf, A. Shah, O. Gutierrez Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int 72 8 2007 1004 1013
11. Y.C. Li, G. Qiao, M. Uskokovic, W. Xiang, W. Zheng, J. Kong Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure J Steroid Biochem Mol Biol 89-90 1-5 2004 387 392
12. J. Sun, J. Kong, Y. Duan Increased NF-kappaB activity in fibroblasts lacking the vitamin D receptor Am J Physiol Endocrinol Metab 291 2 2006 E315 E322
13. J. Cunningham, D. Zehnder New vitamin D analogs and changing therapeutic paradigms Kidney Int 79 7 2011 702 707
14. P. Kandula, M. Dobre, J.D. Schold, M.J. Schreiber Jr, R. Mehrotra, S.D. Navaneethan Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials Clin J Am Soc Nephrol 6 1 2011 50 62
15. I.H. de Boer, G.N. Ioannou, B. Kestenbaum, J.D. Brunzell, N.S. Weiss 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis 50 1 2007 69 77
16. M.L. Melamed, B. Astor, E.D. Michos, T.H. Hostetter, N.R. Powe, P. Muntner 25-Hydroxyvitamin D levels, race, and the progression of kidney disease J Am Soc Nephrol 20 12 2009 2631 2639
17. T. Isakova, O.M. Gutierrez, N.M. Patel, D.L. Andress, M. Wolf, A. Levin Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions J Ren Nutr 21 4 2011 295 302
18. P. Ravani, F. Malberti, G. Tripepi Vitamin D levels and patient outcome in chronic kidney disease Kidney Int 75 1 2009 88 95
19. S. Pilz, S. Iodice, A. Zittermann, W.B. Grant, S. Gandini Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies Am J Kidney Dis 58 3 2011 374 382
20. D.W. Dunstan, P.Z. Zimmet, T.A. Welborn The Australian Diabetes, Obesity and Lifestyle Study (AusDiab) - methods and response rates Diabetes Res Clin Pract 57 2 2002 119 129
21. K.R. Polkinghorne, Q. Su, S.J. Chadban, J.E. Shaw, P.Z. Zimmet, R.C. Atkins Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) Study: immunonephelometry compared with high-performance liquid chromatography Am J Kidney Dis 47 4 2006 604 613
22. M.J. Damasiewicz, D.J. Magliano, R.M. Daly 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study BMC Nephrol 13 2012 55
23. C. Gagnon, Z.X. Lu, D.J. Magliano Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle Study) Diabetes Care 34 5 2011 1133 1138
24. IOM Dietary reference intakes for calcium and vitamin D http://www.iom.edu/Reports/2010/Dietary-Reference-Intakes-for-Calcium-and- Vitamin-D/Report-Brief.aspx 2010 Accessed November 8, 2012
25. E. Giovannucci, Y. Liu, B.W. Hollis, E.B. Rimm 25-Hydroxyvitamin D and risk of myocardial infarction in men: a prospective study Arch Intern Med 168 11 2008 1174 1180
26. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease Am J Kidney Dis 49 suppl 2 2007 S12 S154 (2)
27. A.S. Levey, L.A. Stevens, C.H. Schmid A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
28. National Kidney Foundation K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: evaluation, classification, and stratification Am J Kidney Dis 39 suppl 1 2002 S1 S266 (2)
29. W.C. Knowler, D.J. Pettitt, P.J. Savage, P.H. Bennett Diabetes incidence in Pima indians: contributions of obesity and parental diabetes Am J Epidemiol 113 2 1981 144 156
30. M.J. Kim, A.H. Frankel, M. Donaldson Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition Kidney Int 80 8 2011 851 860
31. R. Agarwal, M. Acharya, J. Tian Antiproteinuric effect of oral paricalcitol in chronic kidney disease Kidney Int 68 6 2005 2823 2828
32. D. de Zeeuw, R. Agarwal, M. Amdahl Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL Study): a randomised controlled trial Lancet 376 9752 2010 1543 1551
33. J.S. Adams, M. Hewison Update in vitamin D J Clin Endocrinol Metab 95 2 2010 471 478
34. I.H. de Boer, R. Katz, M. Chonchol Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate Clin J Am Soc Nephrol 6 9 2011 2141 2149
35. C.M. O'Seaghdha, S.J. Hwang, R. Holden, S.L. Booth, C.S. Fox Phylloquinone and vitamin D status: associations with incident chronic kidney disease in the Framingham Offspring cohort Am J Nephrol 36 1 2012 68 77
36. B.I. Freedman, T.C. Register Effect of race and genetics on vitamin D metabolism, bone and vascular health Nat Rev Nephrol 8 8 2012 459 466
37. S.L. White, K.R. Polkinghorne, R.C. Atkins, S.J. Chadban Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and Lifestyle) Study Am J Kidney Dis 55 4 2010 660 670
38. C. Dai, D.B. Stolz, L.P. Kiss, S.P. Monga, L.B. Holzman, Y. Liu Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria J Am Soc Nephrol 20 9 2009 1997 2008
39. W. He, Y.S. Kang, C. Dai, Y. Liu Blockade of Wnt/beta-catenin signaling by paricalcitol ameliorates proteinuria and kidney injury J Am Soc Nephrol 22 1 2011 90 103
40. Y.C. Li, J. Kong, M. Wei, Z.F. Chen, S.Q. Liu, L.P. Cao 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system J Clin Invest 110 2 2002 229 238
41. G. Qiao, J. Kong, M. Uskokovic, Y.C. Li Analogs of 1alpha,25- dihydroxyvitamin D(3) as novel inhibitors of renin biosynthesis J Steroid Biochem Mol Biol 96 1 2005 59 66
42. C. Ruster, G. Wolf Renin-angiotensin-aldosterone system and progression of renal disease J Am Soc Nephrol 17 11 2006 2985 2991
43. C. Guijarro, J. Egido Transcription factor-kappa B (NF-kappa B) and renal disease Kidney Int 59 2 2001 415 424
44. X. Tan, Y. Li, Y. Liu Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy J Am Soc Nephrol 17 12 2006 3382 3393
45. K. Makibayashi, M. Tatematsu, M. Hirata A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis Am J Pathol 158 5 2001 1733 1741
46. M. Mizobuchi, J. Morrissey, J.L. Finch Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats J Am Soc Nephrol 18 6 2007 1796 1806
47. A.S. Dusso, M. Tokumoto Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease Kidney Int 79 7 2011 715 729
48. 3 Cell 96 4 1999 507 515
49. F. Takemoto, T. Shinki, K. Yokoyama Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats Kidney Int 64 2 2003 414 420
50. R. Jorde, M. Sneve, M. Hutchinson, N. Emaus, Y. Figenschau, G. Grimnes Tracking of serum 25-hydroxyvitamin D levels during 14 years in a population-based study and during 12 months in an intervention study Am J Epidemiol 171 8 2010 903 908
51. J. Hsia, G. Heiss, H. Ren Calcium/vitamin D supplementation and cardiovascular events Circulation 115 7 2007 846 854
52. 3 and/or calcium (RECORD Trial) J Clin Endocrinol Metab 97 2 2012 614 622
53. R.N. Moorthi, P. Kandula, S.M. Moe Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question Curr Opin Nephrol Hypertens 20 4 2011 354 359